Enterally dosed recombinant human erythropoietin does not stimulate erythropoiesis in neonates

Journal of Pediatrics

Volumn 143, Issue 3, 2003, Pages 321-326

  Juul, Sandra E ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN; HEME; PLACEBO; PROTOPORPHYRIN ZINC; RECOMBINANT ERYTHROPOIETIN;

ANEMIA; APNEA; ARTICLE; BLOOD ANALYSIS; BLOOD TRANSFUSION; BRADYCARDIA; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DRUG TOLERABILITY; ENTERIC FEEDING; ERYTHROPOIESIS; HEMATOCRIT; HUMAN; INFANT; LABORATORY TEST; NEWBORN; PHLEBOTOMY; PRACTICE GUIDELINE; PREMATURITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RETICULOCYTE COUNT; SINGLE BLIND PROCEDURE;

EID: 0141615889     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1067/S0022-3476(03)00296-8     Document Type: Article

References (27)

1. Ohls RK, Ehrenkranz RA, Wright LL, Lemons JA, Korones SB, Stoll BJ, et al. Effects of early erythropoietin therapy on the transfusion requirements of preterm infants below 1250 grams birth weight: a multicenter, randomized, controlled trial. Pediatrics 2001;108:934-42.
2. Garcia MG, Hutson AD, Christensen RD. Effect of recombinant erythropoietin on "late" transfusions in the neonatal intensive care unit: a meta-analysis. J Perinatol 2002;22:108-11.
3. Maitani Y, Moriya H, Shimoda N, Takayama K, Nagai T. Distribution characteristics of entrapped recombinant human erythropoietin in liposomes and its intestinal absorption in rats. Int J Pharmacol 1999;185:13-22.
4. Garofalo RP, Goldman AS. Cytokines, chemokines, and colony-stimulating factors in human milk: the 1997 update. Biol Neonate 1998;74:134-42.
5. Rao RK, Lam K, Philipps AF, Williams C, Lake M, Koldovsky O. Presence of multiple forms of peptidase inhibitors in rat milk. J Pediatr Gastroenterol Nutr 1993;17:414-20.
6. Lebenthal A, Lebenthal E. The ontogeny of the small intestinal epithelium. JPEN J Parenter Enteral Nutr 1999;23:S3-6.
7. Rodriguez-Palmero M, Koletzko B, Kunz C, Jensen R. Nutritional and biochemical properties of human milk, II: lipids, micronutrients, and bioactive factors. Clin Perinatol 1999;26:335-59.
8. Miller-Gilbert AL, Dubuque SH, Dvorak B, Williams CS, Grille JG, Woodward SS, et al. Enteral absorption of erythropoietin in the suckling rat. Pediatr Res 2001;50:261-7.
9. Clapp JF III, Little KD, Appleby-Wineberg SK, Widness JA. The effect of regular maternal exercise on erythropoietin in cord blood and amniotic fluid. Am J Obstet Gynecol 1995;172:1445-51.
10. Kling PJ, Sullivan TM, Roberts RA, Philipps AF, Koldovsky O. Human milk as a potential enteral source of erythropoietin. Pediatr Res 1998;43:216-21.
11. Juul SE, Zhao Y, Dame JB, Du Y, Hutson AD, Christensen RD. Origin and fate of erythropoietin in human milk. Pediatr Res 2000;48:660-7.
12. Juul SE, Ledbetter DJ, Joyce AE, Dame C, Christensen RD, Zhao Y, et al. Erythropoietin acts as atrophic factor in neonatal rat intestine. Gut 2001;49:182-9.
13. Juul SE, Yachnis AT, Christensen RD. Tissue distribution of erythropoietin and erythropoietin receptor in the developing human fetus. Early Hum Dev 1998;52:235-49.
14. Juul SE, Joyce AE, Zhao Y, Ledbetter DJ. Why is erythropoietin present in human milk? Studies of erythropoietin receptors on enterocytes of human and rat neonates. Pediatr Res 1999;46:263-8.
15. Carmichael RD, LoBue J, Gordon AS. Neonatal erythropoiesis, I: peripheral blood erythropoietic parameters: data suggest erythropoietin transfer via maternal milk. Endocr Regul 1992;26:83-8.
16. Carmichael RD, LoBue J, Gordon AS. Neonatal erythropoiesis, II: bone marrow and splenic erythropoietic activity: data suggest erythropoietin transfer via maternal milk. Endocr Regul 1992;26:143-9.
17. Britton JR, Christensen RD. Enteral administration of recombinant erythropoietin to preterm infants. J Perinatol 1995;15:281-3.
18. Ballin A, Bilker-Reich A, Arbel E, Davidovitz Y, Kohelet D. Erythropoietin, given enterally, stimulates erythropoiesis in premature infants. Lancet 1999;353:1849.
19. Juul SE, Christensen RD. Absorption of enteral recombinant human erythropoietin by neonates. Ann Pharmacother 2003;37:782-6.
20. Labbe RF, Rettmer RL, Shah AG, Tumlund JR. Zinc protoporphyrin: past, present, and future. Ann N Y Acad Sci 1987;514:7-14.
21. Juul SE, Zerzan JC, Strandjord TP, Woodrum DE. Zinc protoporphyrin/heme as an indicator of iron status in NICU patients. J Pediatr 2003;142:273-8.
22. Ohls RK, Christensen RD. Stability of human recombinant epoetin alfa in commonly used neonatal intravenous solutions. Ann Pharmacother 1996;30:466-8.
23. Ohls RK, Veerman MW, Christensen RD. Pharmacokinetics and effectiveness of recombinant erythropoietin administered to preterm infants by continuous infusion in total parenteral nutrition solution. J Pediatr 1996;128:518-23.
24. Ledbetter DJ, Juul SE. Erythropoietin and the incidence of necrotizing enterocolitis in infants with very low birth weight. J Pediatr Surg 2000;35:178-81.
25. Calhoun DA, Juul SE, McBryde EV, Veerman MW, Christensen RD. Stability of filgrastim and epoetin alfa in a system designed for enteral administration in neonates. Ann Pharmacother 2000;34:1257-61.
26. Sullivan SE, Calhoun DA, Maheshwari A, Ashmeade TL, Auerbach DA, Hudak ML, et al. Tolerance of simulated amniotic fluid in premature neonates. Ann Pharmacother 2002;36:1518-24.
27. Philipps AF, Anderson GG, Dvorak B, Williams CS, Lake M, Lebouton AV, et al. Growth of artificially fed infant rats: effect of supplementation with insulin-like growth factor I. Am J Physiol 1997;272:R1532-9.